Status:
UNKNOWN
Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive System
Lead Sponsor:
Peking University Cancer Hospital & Institute
Conditions:
Gastrointestinal Neoplasms
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
PHASE2
Brief Summary
Ultrasonic sonoporation can increase the release of chemotherapeutics, thus increasing the therapeutic effects. The main purpose is to identify the safety of combining ultrasonic microbubbles and chem...
Detailed Description
Ultrasonic sonoporation can increase the release of chemotherapeutics, thus increasing the therapeutic effects. 1. Main purpose 1. To identify the safety of combining ultrasonic microbubbles and ...
Eligibility Criteria
Inclusion
- Pathological diagnosis of liver metastases from alimentary system and pancreatic carcinoma
- Failed routine chemotherapy
- Neoplasms can be evaluated by imaging
- ECOG《2
Exclusion
- Have systematic chemotherapy in 2 weeks
- Be allergic to ultrasonic microbubbles and chemotherapeutics
- Uncontrolled high blood pressure, cardiovascular disease
- Active bleeding
- Have serious mental and psychological disease
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2016
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT02233205
Start Date
October 1 2014
End Date
June 1 2016
Last Update
July 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Beijing, China, 100142